Apexigen Obtains $20,000,000 Series A Financing

  • Feed Type
  • Date
    8/6/2013
  • Company Name
    Apexigen
  • Mailing Address
    863 Mitten Road Burlingame, CA 94010
  • Company Description
    Apexigen is a biopharmaceutical product development company advancing a pipeline of novel product candidates with the potential to address life-threatening and difficult to treat diseases.
  • Website
    http://www.apexigen.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Financing proceeds will be used to work on an in-house cancer immunotherapy dubbed APX005.
  • M&A Terms
  • Venture Investor
    Amkey Ventures
  • Venture Investor
    CDIB Bioscience
  • Venture Investor
    Themes Investment Partners
  • Venture Investor
    Sycamore Ventures